HTRA1: Serine Protease and Cellular Signaling (G5654)

Target Name: HTRA1

NCBI ID: G5654

HTRA1

HTRA1: Serine Protease and Cellular Signaling

HTRA1 (Serine protease HTRA1) is a protein that is expressed in a variety of tissues throughout the body, including the liver, heart, and kidneys. It is a member of the serine proteases family 1, which includes a number of different proteins that play important roles in the regulation of various cellular processes.

One of the key functions of HTRA1 is its role in the regulation of proteolytic enzymes, which are enzymes that break down other proteins. HTRA1 is involved in the production and degradation of proteolytic enzymes, as well as in the regulation of their activity. This is important because many diseases are caused by the overproduction or underproduction of these enzymes. For example, HTRA1 is often elevated in patients with liver cancer, and is associated with poor prognosis.

HTRA1 is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is important for the development and maintenance of tissues, and is involved in a number of processes, including cell growth, differentiation, and inflammation. HTRA1 has been shown to play a role in the regulation of TGF-β signaling in various tissues, and is often expressed in tissues that are affected by TGF-β-mediated diseases.

In addition to its role in cellular signaling pathways, HTRA1 is also involved in the regulation of various cellular processes that are important for tissue repair and regeneration. For example, HTRA1 is involved in the production and degradation of extracellular matrix (ECM) components, which are important for tissue repair and regeneration following injury or disease.

HTRA1 is also involved in the regulation of inflammation, and is often expressed in tissues that are affected by inflammatory diseases. For example, HTRA1 is involved in the production of inflammatory cytokines, and has been shown to play a role in the regulation of the immune response.

Despite its importance in a number of cellular processes, HTRA1 is not well understood, and is often studied in animal models of disease. There is some evidence to suggest that HTRA1 may be a potential drug target, and may be involved in the development of various diseases. However, more research is needed to fully understand its role and potential clinical applications.

In conclusion, HTRA1 is a protein that is involved in a number of important cellular processes, including the regulation of proteolytic enzymes, cellular signaling pathways, tissue repair and regeneration, and inflammation. It is expressed in a variety of tissues throughout the body, and is potentially involved in the development of many diseases. Further research is needed to fully understand its role and potential clinical applications.

Protein Name: HtrA Serine Peptidase 1

Functions: Serine protease with a variety of targets, including extracellular matrix proteins such as fibronectin. HTRA1-generated fibronectin fragments further induce synovial cells to up-regulate MMP1 and MMP3 production. May also degrade proteoglycans, such as aggrecan, decorin and fibromodulin. Through cleavage of proteoglycans, may release soluble FGF-glycosaminoglycan complexes that promote the range and intensity of FGF signals in the extracellular space. Regulates the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. Inhibits signaling mediated by TGF-beta family members. This activity requires the integrity of the catalytic site, although it is unclear whether TGF-beta proteins are themselves degraded. By acting on TGF-beta signaling, may regulate many physiological processes, including retinal angiogenesis and neuronal survival and maturation during development. Intracellularly, degrades TSC2, leading to the activation of TSC2 downstream targets

The "HTRA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HTRA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets